Australian regulator grants provisional approval for Merck's COVID-19 treatment

by Reuters
Tuesday, 10 August 2021 08:00 GMT

Aug 10 (Reuters) - Australia's pharmaceutical regulator on Tuesday granted provisional approval to Merck & Co's antiviral COVID-19 treatment Molnupiravir. (Reporting by Nikhil Kurian Nainan in Bengaluru; Editing by Subhranshu Sahu)

Our Standards: The Thomson Reuters Trust Principles.